Found: 2
Select item for more details and to access through your institution.
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. E319, doi. 10.1002/ajh.25633
- By:
- Publication type:
- Article
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter